Andy Doraiswamy, Ph.D.
Andy is currently focused on advancing health and human life. He brings innovative teams together to ideate and transform healthcare. He is the founder and CEO of Koya Medical, a team dedicated to transforming chronic lymphatic and venous disease. He also serves as Chairman and board director with an eye-care and urology health venture.
Previously, he led Oculeve, a first-in-class health venture funded by NEA, Kleiner Perkins, and Versant to treat ocular disorders with a revolutionary neuromodulation platform. The company was acquired by Allergan Plc. Prior to this, Andy invented sight-restoring intraocular implants, that have given sight to more than 6 million humans across the globe. This technology was acquired by Santen Pharmaceuticals and licensed to Bausch & Lomb (marketed as envista IOL).
He received his Ph.D. in biomedical engineering from the School of Medicine at University of North Carolina-Chapel Hill, M.S. in materials science and engineering from University of Arizona, and Bachelor's degree in chemical engineering from University of Madras. He has numerous patents and publications in healthcare innovation.
Additionally, Andy enjoys the benefits of meditation & the thrills and agonies of high-altitude mountaineering. He is on a quest to climb the tallest mountains in the world, though this has temporarily taken a back-seat to focus on healthcare. He is actively learning to master the mridangam and enjoys restoring and riding vintage motorcycles.